To get rid of the circulating L-asparagine in ALL patients, type II L-asparaginases from E. coli or E. chrysanthemi are utilized (Radadiya et al., 2020; Andrade et al., 2021). Here, ASPG is linked to acute lymphoblastic leukemia.